The SocietyMore than 35,000 clinicians, scientists and allied health professionals from over 160 countries are part of the ERS communityBecome an ERS member
Assembly 12 and its subsequent Groups focus on interstitial lung diseases. We welcome fellow ERS members specialising in this area or with an interest in this field to join our network.
Assembly 12 has four Groups:
Group 12.02 Chair: Elena Bargagli Secretary: Antoine Froidure
Our group is dedicated to the study, the diagnosis and the treatment of non-idiopathic interstitial lung diseases, namely ILD with an identified trigger. These rare lung diseases often imply that, on top of disease treatment, interventions and control of risk factors are required to dampen symptoms and modify disease course. The main ILD of known origin are ILD related to connective tissue diseases (CTD-ILD), ILD caused by exposure to an airborne toxic or pollutant, from tobacco to aero antigens, drug-related ILD, and pneumoconiosis related to professional and environmental exposure.
The objectives of our group are to improve the knowledge on these complex diseases and to foster collaboration with specialists from related fields like rheumatology, toxicology and pharmacology. We are active in developing guidance and recommendation for diagnosis and treatment of ILD of known origin and eager to develop research collaborations on this topic within the ERS.
Group 12.03 Chair: Paolo Spagnolo Secretary: Marcel Veltkamp
Our group is dedicated to Sarcoidosis and other granulomatous disorders. The priority of group 12.03 is to move forward both education and research in the field of granulomatous disorders with a special focus on sarcoidosis, which includes the largest group of patients within the entire spectrum of ILD. However, sarcoidosis is the prototype of the orphan/neglected disease and patients with sarcoidosis often feel similarly orphan and neglected. Diagnosis and treatment of sarcoidosis is a multidisciplinary exercise, often involving other specialists like cardiologists, neurologists, rheumatologist and many others. Together with other ILD-assemblies, we have developed an ERS School of Sarcoidosis, which will take place in the first half of 2023, in which one of the main focuses will be the multidisciplinary approach to the disease. Along with increasing the interest in sarcoidosis from bench to bedside and the number of group members, the other objective of our assembly is to develop and guide multicenter international studies on Sarcoidosis and other granulomatous disorders.
Group 12.04 Chair: Maria Molina-Molina Secretary: Cormac McCarthy
Rare ILDs involves a group of complex and well-defined ILDs that affects young adults and present a high morbi-mortality. Lymphangioleiomyomatosis (LAM), pulmonary langerhans cell histiocytosis (PLCH), pulmonary alveolar proteinosis (PAP), alveolar microlithiasis, monogenic ILDs, and eosinophilic pneumonia are some of the entities included in this group. The recent advances in genetics, diagnosis and treatment over the last years are currently being translated into clinics.
For this reason, the major objectives of this group are:
Updating education and training on diagnosis and treatment of these ultrarare ILDs through ERS webinars, guidelines, or statements
Enhancing member engagement to participate in clinical and research activities. (The energy and creativity of early career and junior members are more than welcome in this dynamic group!)
Join this assembly
You can join this assembly by selecting it as your main group or one of your optional groups in myERS. Only ERS members can join this assembly. Selections can be changed at any time.
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies. However you may visit Cookie Settings to provide a controlled consent.
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.